It has been a prolific year in eosinophilic esophagitis (EoE) research, particularly of high-impact clinical trials that will undoubtedly alter the current management paradigm. At the AGA postgraduate course in May, we highlighted recent noteworthy randomized controlled trials (RCT) using eosinophil-targeting biologic therapy, esophageal-optimized corticosteroid preparations, and dietary elimination in EoE.
Keep Reading
Add A Comment